Clinical trial: Monoclonal antibody may be an effective alternative to cisplatin in treatment of head and neck cancers

Clinical trial: Monoclonal antibody may be an effective alternative to cisplatin in treatment of head and neck cancers

Head and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report. Smokers and drinkers, as well as those with HPV infections, are disproportionately affected.

​Medical Xpress – latest medical and health news stories

Read More

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *